DE68906248D1 - Antagonisten fuer den platelet-aktivierungsfaktor, phomactine genannt, ihre herstellung und verwendung. - Google Patents
Antagonisten fuer den platelet-aktivierungsfaktor, phomactine genannt, ihre herstellung und verwendung.Info
- Publication number
- DE68906248D1 DE68906248D1 DE8989312361T DE68906248T DE68906248D1 DE 68906248 D1 DE68906248 D1 DE 68906248D1 DE 8989312361 T DE8989312361 T DE 8989312361T DE 68906248 T DE68906248 T DE 68906248T DE 68906248 D1 DE68906248 D1 DE 68906248D1
- Authority
- DE
- Germany
- Prior art keywords
- called
- antagonists
- phomactine
- production
- platelet activation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/32—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by aldehydo- or ketonic radicals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP30027888 | 1988-11-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE68906248D1 true DE68906248D1 (de) | 1993-06-03 |
DE68906248T2 DE68906248T2 (de) | 1993-08-12 |
Family
ID=17882866
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8989312361T Expired - Fee Related DE68906248T2 (de) | 1988-11-28 | 1989-11-28 | Antagonisten fuer den platelet-aktivierungsfaktor, phomactine genannt, ihre herstellung und verwendung. |
Country Status (7)
Country | Link |
---|---|
US (1) | US5151529A (de) |
EP (1) | EP0371762B1 (de) |
KR (1) | KR940004128B1 (de) |
AT (1) | ATE88707T1 (de) |
CA (1) | CA2003956A1 (de) |
DE (1) | DE68906248T2 (de) |
ES (1) | ES2055104T3 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11510388A (ja) * | 1995-07-25 | 1999-09-14 | メルク エンド カンパニー インコーポレーテッド | ファルネシル−タンパク質転移酵素の阻害剤 |
US5663193A (en) * | 1995-07-25 | 1997-09-02 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
JP4123106B2 (ja) | 2003-08-22 | 2008-07-23 | ソニー株式会社 | 有機el素子 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6339591A (ja) * | 1986-08-04 | 1988-02-20 | Nippon Kayaku Co Ltd | 新規生理活性物質NK−A−17−e−233およびその製造法 |
JPS63307872A (ja) * | 1987-06-09 | 1988-12-15 | Nippon Kayaku Co Ltd | 新規生理活性物質NK−A−17−e−233−4およびその製造法 |
-
1989
- 1989-11-27 CA CA002003956A patent/CA2003956A1/en not_active Abandoned
- 1989-11-28 ES ES89312361T patent/ES2055104T3/es not_active Expired - Lifetime
- 1989-11-28 AT AT89312361T patent/ATE88707T1/de not_active IP Right Cessation
- 1989-11-28 EP EP89312361A patent/EP0371762B1/de not_active Expired - Lifetime
- 1989-11-28 DE DE8989312361T patent/DE68906248T2/de not_active Expired - Fee Related
- 1989-11-28 KR KR1019890017327A patent/KR940004128B1/ko not_active IP Right Cessation
-
1990
- 1990-10-10 US US07/596,580 patent/US5151529A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE68906248T2 (de) | 1993-08-12 |
US5151529A (en) | 1992-09-29 |
KR940004128B1 (ko) | 1994-05-13 |
CA2003956A1 (en) | 1990-05-28 |
KR900008048A (ko) | 1990-06-02 |
ATE88707T1 (de) | 1993-05-15 |
EP0371762A3 (de) | 1991-03-20 |
ES2055104T3 (es) | 1994-08-16 |
EP0371762A2 (de) | 1990-06-06 |
EP0371762B1 (de) | 1993-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2124479T3 (es) | Composiciones biocidas. | |
ATE200279T1 (de) | Herstellung von 3,4,4-trisubstituiertem piperidinyl-n-alkylcarboxylaten und zwischenverbindungen, verwendbar als opioid antagonisten | |
NO912630D0 (no) | Fremgangsmaate for fremstilling av nye 2,6-dialkyl-4-silyl-fenoler. | |
AU8979191A (en) | 3,7-disubstituted indole derivatives | |
AU671818B2 (en) | Halichondrins | |
ATE126509T1 (de) | Disäuren von diarylstyrylchinolin. | |
FI920023A0 (fi) | Heteroarylpiperazinfoereningar som antipsykotiska aemnen. | |
DE69525354D1 (de) | Eine neuartige medizinische verwendung eines 5ht 3-antagonisten | |
EP0318084A3 (de) | Benzoheterazole | |
FR2684103B1 (fr) | Nouveaux composes a structure guanidique et composition pharmaceutique les contenant. | |
TW257750B (de) | ||
IT1212143B (it) | Composizione ad attivita'tricogena. | |
DE58904434D1 (de) | Organische derivate von rheniumoxiden sowie ihre herstellung und verwendung zur metathese von olefinen. | |
ATE113591T1 (de) | 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol- - one und ihre verwendung als antikonvulsiva. | |
DE68906248D1 (de) | Antagonisten fuer den platelet-aktivierungsfaktor, phomactine genannt, ihre herstellung und verwendung. | |
ES2061794T3 (es) | Nuevos derivados de benzazepina. | |
DE3751362D1 (de) | 5-Aryl-3H-1,2,4-triazol-3-one und ihre Verwendung als Antikonvulsiva. | |
EP0354184A3 (de) | Substituierte Piperidinverbindungen und ihrer Verwendung als Stabilisatoren für organische Materialien | |
DE68903907D1 (de) | Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen. | |
DE3582890D1 (de) | 2-oxindolzwischenprodukte. | |
DE69333302D1 (de) | Mikroorganismen, ihre herstellung und verwendung | |
FI901277A0 (fi) | 2,5,6,7-tetranor-4,8-inter-m-fenylen pg1z-derivativ. | |
WO1990007260A3 (en) | 2,3-methanoproline | |
ATE88634T1 (de) | Arzneimittel zur behandlung von herzinsuffizienz. | |
AT388566B (de) | Neues antibiotikum a 42867 und dessen additionssalze |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |